Receptor Interacting Protein Kinases 1/3: The Potential Therapeutic Target for Cardiovascular Inflammatory Diseases
The receptor interacting protein kinases 1/3 (RIPK1/3) have emerged as the key mediators in cell death pathways and inflammatory signaling, whose ubiquitination, phosphorylation, and inhibition could regulate the necroptosis and apoptosis effectually. Recently, more and more studies show great inter...
Guardado en:
Autores principales: | Yiming Leng, Ying Zhang, Xinyu Li, Zeyu Wang, Quan Zhuang, Yao Lu |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/5d343e3d5b5044259eb101c1571864bc |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Species-Specific Inhibition of Necroptosis by HCMV UL36
por: Elena Muscolino, et al.
Publicado: (2021) -
RIPK3-Dependent Recruitment of Low-Inflammatory Myeloid Cells Does Not Protect from Systemic <italic toggle="yes">Salmonella</italic> Infection
por: John Satkovich, et al.
Publicado: (2020) -
Silica nanoparticles induce reversible damage of spermatogenic cells via RIPK1 signal pathways in C57 mice
por: Ren L, et al.
Publicado: (2016) -
Receptor-Interacting Protein Kinase 3 Inhibition Prevents Cadmium-Mediated Macrophage Polarization and Subsequent Atherosclerosis via Maintaining Mitochondrial Homeostasis
por: Jiexin Zhang, et al.
Publicado: (2021) -
A canthin-6-one derivative induces cell death by apoptosis/necroptosis-like with DNA damage in acute myeloid cells
por: Heron F.V. Torquato, et al.
Publicado: (2022)